Skip to main content

10-10-2018 | Multiple sclerosis | Video

ECTRIMS 2018: Ongoing relapse activity is a suitable treatment target in secondary-progressive multiple sclerosis

Nathaniel Lizak presents study findings showing that ongoing relapse in patients with multiple sclerosis is not a contraindication to disease-modifying treatment (2:19).

Funding for this video was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Image Credits